Lead generation approaches in drug discovery
I tiakina i:
Kaituhi rangatōpū: | ebrary, Inc |
---|---|
Ētahi atu kaituhi: | Rankovic, Zoran, Morphy, Richard |
Hōputu: | Tāhiko īPukapuka |
Reo: | Ingarihi |
I whakaputaina: |
Hoboken, NJ :
Wiley,
c2010.
|
Ngā marau: | |
Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
Target validation in drug discovery
I whakaputaina: (2006)
I whakaputaina: (2006)
High-throughput screening methods in toxicity testing
I whakaputaina: (2013)
I whakaputaina: (2013)
In silico lead discovery
mā: Miteva, Maria A.
I whakaputaina: (2011)
mā: Miteva, Maria A.
I whakaputaina: (2011)
Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015)
I whakaputaina: (2015)
Analogue-based drug discovery III
I whakaputaina: (2013)
I whakaputaina: (2013)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)
I whakaputaina: (2012)
Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)
mā: Zanders, Edward D.
I whakaputaina: (2016)
Data mining in drug discovery /
I whakaputaina: (2014)
I whakaputaina: (2014)
Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)
I whakaputaina: (2013)
Drug discovery handbook
I whakaputaina: (2005)
I whakaputaina: (2005)
Biological drug products : development and strategies /
I whakaputaina: (2013)
I whakaputaina: (2013)
ADME-enabling technologies for drug design and development
I whakaputaina: (2012)
I whakaputaina: (2012)
Retrometabolic drug design and targeting
mā: Bodor, Nicholas
I whakaputaina: (2012)
mā: Bodor, Nicholas
I whakaputaina: (2012)
The quest for the cures the science, stories and struggles behind the next generation of medicines /
mā: Stockwell, Brent R.
I whakaputaina: (2011)
mā: Stockwell, Brent R.
I whakaputaina: (2011)
A mathematical approach to multilevel, multiscale health interventions pharmaceutical industry decline and policy response /
mā: Wallace, Rodrick
I whakaputaina: (2013)
mā: Wallace, Rodrick
I whakaputaina: (2013)
Molecular pathology in drug discovery and development
I whakaputaina: (2009)
I whakaputaina: (2009)
Systems biology in drug discovery and development
I whakaputaina: (2011)
I whakaputaina: (2011)
In vivo models for drug discovery /
I whakaputaina: (2014)
I whakaputaina: (2014)
Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
Pharmacokinetics and metabolism in drug design
I whakaputaina: (2012)
I whakaputaina: (2012)
Drug discovery and design medical aspects /
I whakaputaina: (2002)
I whakaputaina: (2002)
Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
I whakaputaina: (2010)
I whakaputaina: (2010)
Drug development principles, methodology and emerging challenges /
I whakaputaina: (2013)
I whakaputaina: (2013)
Global new drug development : an introduction /
mā: Rosier, Jan A., me ētahi atu.
I whakaputaina: (2014)
mā: Rosier, Jan A., me ētahi atu.
I whakaputaina: (2014)
Collaborative innovation in drug discovery : strategies for public and private partnerships /
I whakaputaina: (2014)
I whakaputaina: (2014)
Peptide chemistry and drug design /
I whakaputaina: (2015)
I whakaputaina: (2015)
A comprehensive guide to toxicology in preclinical drug development
I whakaputaina: (2013)
I whakaputaina: (2013)
Introduction to biological and small molecule drug research and development theory and case studies /
I whakaputaina: (2013)
I whakaputaina: (2013)
Formulation and analytical development for low-dose oral drug products
I whakaputaina: (2009)
I whakaputaina: (2009)
Applications of transition metal catalysis in drug discovery and development an industrial perspective /
I whakaputaina: (2012)
I whakaputaina: (2012)
Lead optimization for medicinal chemists pharmacokinetic properties of functional groups and organic compounds /
mā: Dörwald, Florencio Zaragoza
I whakaputaina: (2012)
mā: Dörwald, Florencio Zaragoza
I whakaputaina: (2012)
Protein and peptide mass spectrometry in drug discovery
I whakaputaina: (2012)
I whakaputaina: (2012)
Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)
mā: Ng, Rick
I whakaputaina: (2015)
Drug utilization research : methods and applications /
I whakaputaina: (2016)
I whakaputaina: (2016)
Statistical issues in drug development
mā: Senn, Stephen
I whakaputaina: (2007)
mā: Senn, Stephen
I whakaputaina: (2007)
Early drug development strategies and routes to first-in-human trials /
I whakaputaina: (2010)
I whakaputaina: (2010)
Oral bioavailability basic principles, advanced concepts, and applications /
I whakaputaina: (2011)
I whakaputaina: (2011)
3D QSAR in drug design
I whakaputaina: (2002)
I whakaputaina: (2002)
Drug metabolism prediction /
I whakaputaina: (2014)
I whakaputaina: (2014)
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
Ngā tūemi rite
-
Target validation in drug discovery
I whakaputaina: (2006) -
High-throughput screening methods in toxicity testing
I whakaputaina: (2013) -
In silico lead discovery
mā: Miteva, Maria A.
I whakaputaina: (2011) -
Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015) -
Analogue-based drug discovery III
I whakaputaina: (2013)